Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function

Pain

Volumn 85, Issue 1-2, 2000, Pages 153-159

  Tershner, Sheralee A ^a   Mitchell, Jennifer M ^b   Fields, Howard L ^b  

^a 1215 W   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antinociception; Descending control; Opioid analgesia; Pain modulation; Rostral ventromedial medulla

Indexed keywords

KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN STEM RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HISTOPATHOLOGY; MALE; NEUROMODULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANALGESICS, OPIOID; ANIMALS; BRAIN STEM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FEMALE; INJECTIONS; MALE; MORPHINE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SEX CHARACTERISTICS; TIME FACTORS;

EID: 0033966263     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00257-2     Document Type: Article

References (41)

1. Ali B., Sharif S., Elkadi A. Sex differences and the effect of gonadectomy on morphine-induced antinociception and dependence in rats and mice. Clin Exp Pharm Physiol. 22:1995;342-344.
2. Azami J., Llewelyn M.B., Roberts M.H. The contribution of nucleus reticularis paragigantocellularis and nucleus raphe magnus to the analgesia produced by systemically administered morphine, investigated with the microinjection technique. Pain. 12:1982;229-246.
3. Bartok R.E., Craft R.M. Sex differences in opioid antinociception. J Pharmacol Exp Ther. 282:1997;769-778.
4. Bodnar R.J., Williams C.L., Lee S.J., Pasternak G.W. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study. Brain Res. 447:1988;25-34.
5. Bolanos C.A., Garmsen G.M., Clair M.A., McDougall S.A. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat. Eur J Pharmacol. 317:1996;1-8.
6. Boyer J.S., Morgan M.M., Craft R.M. Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats. Brain Res. 796:1998;315-318.
7. Candido J., Lufty K., Billings B., Sierra V., Duttaroy A., Inturrisi C.E., Yoburn B.C. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharm Biochem Behav. 42:1992;685-692.
8. Cicero T., Nock B., Meyer E. Gender-related differences in antinociceptive properties of morphine. J Pharmacol Exp Ther. 279:1996;767-773.
9. DeKock M., Scholtes J. Postoperative PCA in abdominal surgery: Analysis of 200 consecutive patients. Acta Anaesthesiol Belg. 42:1991;85-91.
10. Dickenson A.H., Oliveras J.L., Besson J.M. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat. Brain Res. 170:1979;95-111.
11. Fields H.L., Basbaum A.I. Central nervous system mechanisms of pain modulation. Wall P.D., Melzack R. Textbook of Pain. 3 :1994;243-257 Churchill Livingstone, Edinburgh.
12. Fields H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulating circuits. Annu Rev Neurosci. 14:1991;219-246.
13. Friedman H.J., Jen M.F., Chang J.K., Lee N.M., Loh H.H. Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse. Eur J Pharmacol. 69:1981;357-360.
14. Funada M., Suzuki T., Narita M., Misawa M., Nagase H. Blockade of morphine reward through the activation of mu-opioid receptors in mice. Neuropharmacology. 32:1993;1315-1323.
15. Gear R., Gordon N., Heller P., Paul S., Miaskowski C., Levine J. Gender differences in analgesic response to the kappa-opioid pentazocine. Neurosci Lett. 205:1996;207-209.
16. Gear R., Miaskowski C., Gordon N., Paul S., Heller P. L., Levine L. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med. 2:1996;1248-1250.
17. Glick S.D., Maisonneuve I.M., Raucci J., Archer S. Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res. 681:1995;147-152.
18. Hammer R.P. Jr. The sexually dimorphic region of the preoptic area in rats contains denser opiate receptor binding sites in females. Brain Res. 308:1984;172-176.
19. Hammer R.P. Jr. Mu opioid receptor binding in the medial preoptic area is cyclical and sexually dimorphic. Brain Res. 515:1990;187-192.
20. Heinricher M.M., Barbaro N.M., Fields H.L. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: Firing of On- and Off- cells is related to nociceptive responsiveness. Somatosens Motor Res. 6:1989;427-439.
21. Islam A.K., Cooper M.L., Bodnar R.J. Interactions among aging, gender, and gonadectomy effects upon morphine antinociception in rats. Physiol Behav. 54:1993;45-53.
22. Jensen T.S., Yaksh T.L. Comparisons of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Brain Res. 372:1986;301-312.
23. Kavaliers M., Innes D. Sex and day-night differences in opiate-induced responses of insular wild deer mice, Peromyscus maniculatus triangularis. Pharmacol Biochem Behavior. 27:1987;477-482.
24. Kavaliers M., Innes D. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress- induced analgesia. Peptides. 13:1992;603-607.
25. Kepler K.L., Kest B., Kiefel J.M., Cooper M.L., Bodnar R.J. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol Biochem Behav. 34:1989;119-127.
26. Kepler K., Standifer K., Paul D., Kest B. Gender effects and central opioid analgesia. Pain. 45:1991;87-94.
27. Kuzmin A.V., Semenova S., Gerrits M.A., Zvartau E.E., Van Ree J.M. Kappa-opioid receptor agonist, U50,488H modulates cocaine and morphine self-administration in drug naïve rats and mice. Eur J Pharmacol. 321:1997;265-271.
28. Lipa S., Kavaliers M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res Bull. 24:1990;627-630.
29. Manning B., Franklin K.B. Morphine analgesia in the formalin test: reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray. Behav Brain Res. 92:1998;97-102.
30. Pan Z.Z. Mu opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci. 19:1998;94-98.
31. Pan Z.Z., Williams J.T., Osborne P. Opioid actions on single raphe magnus neurons from rat and guinea pig in vitro. J Physiol. 427:1990;519-532.
32. Pan Z.Z., Tershner S.A., Fields H.L. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature. 389:1997;382-385.
33. Paxinos G., Watson D. The Rat Brain in Stereotaxic Coordinates. 2 :1986;Academic, San Diego.
34. Ramarao P., Jablonski H.I. Jr, Rehder K.R., Bhargava H.N. Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naïve and morphine-tolerant rats. Eur J Pharmacol. 156:1988;239-246.
35. Smith D.J., Perotti J.M., Crisp T., Cabral M.E., Long J.T., Scalzitti J.M. The mu opiate receptor is responsible for descending pain inhibition in the periaqueductal gray region of the rat brain. Eur J Pharmacol. 156:1988;47-54.
36. Song Z.H., Takemori A.E. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception. Life Sci. 48:1991;1447-1453.
37. Takahashi M., Senda T., Kaneto H. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Eur J Pharmacol. 200:1991;293-297.
38. Takemori A.E., Loh H.H., Lee N.M. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur J Pharmacol. 221:1992;223-226.
39. Tao P.L., Hwang C.L., Chen Y. U50488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Eur J Pharmacol. 256:1994;281-286.
40. Tulaney F.C., Jen M.F., Chang J.K., Lee N.M. Possible regulatory role of dynorphin on morphine and endorphin-dependent analgesia. J Pharmacol Exp Ther. 219:1981;296-298.
41. Yamamoto T., Ohno M., Ueki S. A selective kappa-opioid agonist, U50488, blocks the development of tolerance to morphine analgesia in rats. Eur J Pharmacol. 156:1988;173-176.